INTRODUCTION AND OBJECTIVES: Mini-percutaneous nephrolithotomy (mini-PCNL) was initially described in the late 1990s. Many variations on the technique have been described since that time focusing on differing access sizes. Lithotripsy through a mini-PCNL tract has traditionally been accomplished through laser or electro-hydraulic/ pneumatic energy. We sought to explore the feasibility of lithotripsy through a mini-PCNL tract with the Olympus ShockPulse-SE Lithotripter which combines both ultrasonic and mechanical energy to optimize lithotripsy.
INTRODUCTION AND OBJECTIVES: Mini-percutaneous nephrolithotomy (mini-PCNL) was initially described in the late 1990s. Many variations on the technique have been described since that time focusing on differing access sizes. Lithotripsy through a mini-PCNL tract has traditionally been accomplished through laser or electro-hydraulic/ pneumatic energy. We sought to explore the feasibility of lithotripsy through a mini-PCNL tract with the Olympus ShockPulse-SE Lithotripter which combines both ultrasonic and mechanical energy to optimize lithotripsy.
METHODS: A 58 year male patient with a 2.5 cm left lower pole stone was identified as the initial candidate for our technique. He was positioned in the standard prone position and access was obtained into his lower pole with an 18-gauge Cook LS access needle. We proceeded to dilate a 16-French tract using a one-step dilator with the Storz Modular Minimally Invasive PCNL (MIP) System. With the Storz MIP M nephroscope and a 1.5 mm Olympus ShockPulse-SE probe, we then broke the stone into minute fragments which were initially suctioned and collected with the StoneCatcher (Boston Scientific) system. Remaining fragments were removed with an endoscopic grasper and a nitinol stone basket. The procedure was performed tubeless with a stent. After five days, a follow-up plain film was obtained and the stent removed.
RESULTS: The dual modality lithotripter was efficient with stone fragmentation and extraction through suction. The total operative time was 110 minutes. The patient was discharged on post-operative day one after an uncomplicated stay of 30 hours total duration. Postoperatively, his hemoglobin declined 2.3 g/dl and his creatinine rose 0.2 mg/dl. On return, his large 2.5 cm stone showed good clearance on KUB though dust like fragments (< 2 mm) remained in his lower pole.
CONCLUSIONS: This is the first report of using integrated ultrasonic and mechanical energy lithotripsy in a mini-PCNL. The combination of the Olympus ShockPulse-SE Lithotripter with the Storz MIP system proved efficient in terms of operative duration and stone breakdown. It was also effective at clearing a large stone burden through a small 16-French tract. This method is feasible and provides an alternative to laser or pneumatic lithotripsy and offers the benefits of suction.
Source of Funding: none

V11-11 THULIUM LITHOTRIPSY: FROM EXPERIMENT TO CLINICAL PRACTICE
Alim Dymov*, Petr Glybochko, Yuri Alyaev, Andrey Vinarov, Moscow, Russian Federation; Gregory Altshuler, Boston, MA; Viktoria Zamyatina, Fryazinno, Russian Federation; Nikolay Sorokin, Dmitri Enikeev, Vladimir Lekarev, Alexandra Proskura, Alexey Koshkarev, Moscow, Russian Federation INTRODUCTION AND OBJECTIVES: To date Holmium (Ho) laser is one of the most popular and effective tools for lithotripsy. It emits very short pulses (0.1 e 1 ms) with high peak power (0.5-10 kW) that allows to efficiently fragment any type of urinary stones. Series of articles show Ho laser wavelength of 2.1 mm is significantly off the peak of water absorption, and so can negatively affect efficiency of stone fragmentation. They also stressed that the thulium (Tm) fiber laser with diode laser pumping can improve stone fragmentation, because emission of Tm laser with wavelength 1.94 mm is 4.5 times stronger absorbed by water than that of Ho laser. There is a lot of data on feasibility and efficacy of Tm laser application for stone fragmentation in vitro. Nevertheless, Thulium laser lithotripsy hasn't been widely utilized in the clinical settings. A prototype Tm fiber laser with a peak power up to 500 W were developed by NTO «IRE e Polus» METHODS: We have evaluated in vitro performance of a prototype Tm fiber laser with a peak power up to 500 W as a potentially alternative for modern Ho laser system. The in vitro experimental setup for measuring the stone fragmentation rate (ablation rate) included a specially designed cuvette with several levels of meshes allowing for precise quantification of size distribution of stone fragments (for the modes of fragmentation and dusting). Post e surgery human stones and BegoStone phantoms were used. The laser parameters (pulse energy and average power) were identical. Also retropulsion effect caused by a single pulse has been evaluated. Lateral shift of a stone after a single pulse of laser energy was measured.
RESULTS: U Proposed experimental technique offers relatively simple and reliable method of comparing performance of laser lithotripters under controlled ex vivo conditions U The Tm system, at identical laser parameters, produced about 2.3 and 1.3 times greater average ablation rate than the Ho system does in dusting and fragmentation modes, respectively U The ratio of ablation rates on Bego-Stone phantoms correlated well with human stone data and varied between 1.6 and 2.3 U The effect of retropulsion of the Tm laser (at 500 W) was 75%, 60%, and 29% of that of the Ho laser for equal pulse energies of 1, 2, and 3 J, respectively. The retropulsion onset threshold was significantly higher for Tm laser CONCLUSIONS: Supported by this experimental data we assessed the clinical effectiveness of Tm fiber Urolase system with peak power of 120 W for lithotripsy. Several bladder stones with the average size about 1.9 cm were successfully destroyed. Further investigation in to the clinical applicability of Thulium lithotripsy is required.
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V11-12 HOLMIUM LASER SETTINGS DURING LITHOTRIPSY OF DIFFERENT TYPES OF KIDNEY STONES
Oriol Angerri*, Juan Manuel L opez, Pavel Gavrilov, Francisco S anchez-Martín, F elix Mill an, Humberto Villavicencio, Barcelona, Spain INTRODUCTION AND OBJECTIVES: Currently, holmium laser is the most versatile energy source for the treatment of intrarenal stones by intracorporeal lithotripsy since it may be used with both flexible and rigid endoscopes, permitting access to all parts of the kidney. Highpower laser enables the destruction of all kinds of stones, but the settings most suitable for the treatment of individual types remain to be defined.
METHODS: In the operation theatre we used a pelvic trainer into which we introduced six different types of urinary stones from our stone library: uric acid, cystine, struvite, brushite, calcium oxalate monohydrate, and calcium oxalate dihydrate. Ex vivo lithotripsy was performed by means of continuous serum irrigation with the Lumenis VersaPulse 120 W high-power laser, with a 550-micron fibre. Power, frequency, and potency parameters, as well as the short-pulse/longpulse variable, were varied among the six different types of stones.
RESULTS: In all cases lithotripsy was commenced using low power and frequency: 0.2 J and 10 Hz. Power and frequency were raised up to a maximum of 3 J and 40 Hz, according to the type of stone, and until maximum potencies close to 120 W were obtained. The difference in hardness of the investigated types of stones required differing power settings according to whether fragmentation into large pieces or pulverisation was desired. The different power settings used for the various types of stones are described, and the fragmentation ability and speed of the holmium laser are appraised.
CONCLUSIONS: High-power laser is useful for destruction of any type of urinary stone. The harder the stone, the greater is the potency needed; however, the frequency is not so important. Low power is able to yield good results on soft stones, and excellent pulverisation can be obtained by increasing the pulse frequency. The long pulse is very useful for lowering the stone retropulsion and increasing pulverisation, particularly in the case of softer stones. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1285
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